MetaADEDB 2.0 @ LMMD
Albuterol
(BNPSSFBOAGDEEL-UHFFFAOYSA-N)
Structure
SMILES
OS(=O)(=O)O.OCc1cc(ccc1O)C(CNC(C)(C)C)O.OCc1cc(ccc1O)C(CNC(C)(C)C)O
Molecular Formula:
C26H44N2O10S
Molecular Weight:
576.700
Log P:
3.8218
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
10
TPSA:
228.42
CAS Number(s):
36519-31-0; 51022-70-9
Synonym(s)
1.
Albuterol
2.
Salbutamol
3.
2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol
4.
Albuterol Sulfate
5.
Proventil
6.
Sultanol
7.
Ventolin
External Link(s)
MeSHD017265
D000420
PubChem Compound43834519
39859
ChEBI2550
CHEMBLCHEMBL1441059
KEGGdr:D00683
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Device use errorFAERS: 4528US FAERS
2Wrong technique in product usage processFAERS: 3489
Canada Vigilance: 1
Canada Vigilance
US FAERS
3Drug ineffectiveFAERS: 3476
Canada Vigilance: 59
Canada Vigilance
US FAERS
4Product cleaning inadequateFAERS: 1740US FAERS
5Product quality issueFAERS: 1490
Canada Vigilance: 6
Canada Vigilance
US FAERS
6Wrong technique in device usage processFAERS: 1221US FAERS
7Drug dose omissionFAERS: 769US FAERS
8AsthmaFAERS: 747
Canada Vigilance: 156
Canada Vigilance
US FAERS
9Product use issueFAERS: 644US FAERS
10Device malfunctionFAERS: 487US FAERS
11Medication ErrorFAERS: 381US FAERS
12Product storage errorFAERS: 354US FAERS
13MalaiseFAERS: 351
Canada Vigilance: 9
Canada Vigilance
US FAERS
14Expired product administeredFAERS: 341US FAERS
15Product complaintFAERS: 274
Canada Vigilance: 32
Canada Vigilance
US FAERS
16Product dose omissionFAERS: 274
Canada Vigilance: 2
Canada Vigilance
US FAERS
17WheezingFAERS: 273
Canada Vigilance: 28
Canada Vigilance
US FAERS
18Product use in unapproved indicationFAERS: 268US FAERS
19Pharmaceutical product complaintFAERS: 244US FAERS
20Product physical issueFAERS: 212US FAERS
21OverdoseFAERS: 196
Canada Vigilance: 3
Canada Vigilance
US FAERS
22Intentional product use issueFAERS: 157US FAERS
23PneumoniaFAERS: 157
Canada Vigilance: 26
Canada Vigilance
US FAERS
24DizzinessFAERS: 142
Canada Vigilance: 2
Canada Vigilance
US FAERS
25HeadacheFAERS: 141
Canada Vigilance: 3
Canada Vigilance
US FAERS
26Chest discomfortFAERS: 132
Canada Vigilance: 4
Canada Vigilance
US FAERS
27Throat irritationFAERS: 131
Canada Vigilance: 1
Canada Vigilance
US FAERS
28Incorrect product storageFAERS: 130US FAERS
29Product substitution issueFAERS: 129
Canada Vigilance: 1
Canada Vigilance
US FAERS
30Intentional product misuseFAERS: 122
Canada Vigilance: 1
Canada Vigilance
US FAERS
31BronchitisFAERS: 119
Canada Vigilance: 9
Canada Vigilance
US FAERS
32TremorFAERS: 116
Canada Vigilance: 1
Canada Vigilance
US FAERS
33Chest PainFAERS: 114
Canada Vigilance: 6
Canada Vigilance
US FAERS
34NasopharyngitisFAERS: 113
Canada Vigilance: 5
Canada Vigilance
US FAERS
35Incorrect dose administeredFAERS: 111US FAERS
36Inappropriate schedule of drug administrationFAERS: 109US FAERS
37Medication residue presentFAERS: 103US FAERS
38Drug administration errorFAERS: 102US FAERS
39Drug dispensing errorFAERS: 90US FAERS
40Oropharyngeal painFAERS: 90US FAERS
41Device FailureFAERS: 89US FAERS
42Product taste abnormalFAERS: 89
Canada Vigilance: 2
Canada Vigilance
US FAERS
43DysgeusiaFAERS: 82
Canada Vigilance: 1
Canada Vigilance
US FAERS
44Feeling abnormalFAERS: 82
Canada Vigilance: 1
Canada Vigilance
US FAERS
45HypersensitivityFAERS: 82
Canada Vigilance: 2
Canada Vigilance
US FAERS
46Drug effect incompleteFAERS: 77US FAERS
47AnxietyFAERS: 76
Canada Vigilance: 4
Canada Vigilance
US FAERS
48DysphoniaFAERS: 76
Canada Vigilance: 2
Canada Vigilance
US FAERS
49Extra dose administeredFAERS: 73US FAERS
50PalpitationsFAERS: 73
Canada Vigilance: 1
Canada Vigilance
US FAERS
51NauseaFAERS: 71
Canada Vigilance: 1
Canada Vigilance
US FAERS
52Adverse eventFAERS: 66US FAERS
53VomitingFAERS: 62
Canada Vigilance: 1
Canada Vigilance
US FAERS
54Myocardial InfarctionFAERS: 61
Canada Vigilance: 3
Canada Vigilance
US FAERS
55ChokingFAERS: 55
Canada Vigilance: 5
Canada Vigilance
US FAERS
56NervousnessFAERS: 51US FAERS
57Accidental exposure to productFAERS: 50
Canada Vigilance: 1
Canada Vigilance
US FAERS
58Intentional device misuseFAERS: 50US FAERS
59Productive CoughFAERS: 49
Canada Vigilance: 8
Canada Vigilance
US FAERS
60Circumstance or information capable of leading to medication errorFAERS: 46US FAERS
61Feeling jitteryFAERS: 46US FAERS
62InfluenzaFAERS: 44
Canada Vigilance: 6
Canada Vigilance
US FAERS
63PainFAERS: 44
Canada Vigilance: 6
Canada Vigilance
US FAERS
64BronchospasmFAERS: 43
Canada Vigilance: 5
Canada Vigilance
US FAERS
65Drug administered to patient of inappropriate ageFAERS: 43US FAERS
66Breath alcohol test positiveFAERS: 41US FAERS
67Burning sensationFAERS: 41US FAERS
68Cerebrovascular accidentFAERS: 41
Canada Vigilance: 6
Canada Vigilance
US FAERS
69FatigueFAERS: 41
Canada Vigilance: 6
Canada Vigilance
US FAERS
70Wrong patient received medicationFAERS: 41US FAERS
71Inhalation TherapyFAERS: 39US FAERS
72Incorrect dose administered by deviceFAERS: 36US FAERS
73AstheniaFAERS: 34
Canada Vigilance: 4
Canada Vigilance
US FAERS
74Prescription drug used without a prescriptionFAERS: 34US FAERS
75PruritusFAERS: 34US FAERS
76Therapeutic response unexpected with drug substitutionFAERS: 33US FAERS
77Device occlusionFAERS: 32US FAERS
78Incorrect route of drug administrationFAERS: 31US FAERS
79Drug ineffective for unapproved indicationFAERS: 30US FAERS
80Intercepted drug dispensing errorFAERS: 30US FAERS
81SinusitisFAERS: 30
Canada Vigilance: 12
Canada Vigilance
US FAERS
82Device ineffectiveFAERS: 29US FAERS
83Drug prescribing errorFAERS: 29US FAERS
84AphoniaFAERS: 27US FAERS
85Drug effect delayedFAERS: 27US FAERS
86Exposure via skin contactFAERS: 26US FAERS
87UrticariaFAERS: 26
Canada Vigilance: 3
Canada Vigilance
US FAERS
88Economic problemFAERS: 25US FAERS
89Multiple allergiesFAERS: 25US FAERS
90Respiratory tract irritationFAERS: 25US FAERS
91RetchingFAERS: 24US FAERS
92Device leakageFAERS: 23US FAERS
93Device defectiveFAERS: 22US FAERS
94Wrong technique in drug usage processFAERS: 22US FAERS
95Impaired work abilityFAERS: 21US FAERS
96Memory impairmentFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
97Respiratory tract congestionFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
98StressFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
99Thermal burnFAERS: 21US FAERS
100Back PainFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
101Product packaging quantity issueFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
102ErythemaFAERS: 19US FAERS
103Inability to afford medicationFAERS: 19US FAERS
104LaryngitisFAERS: 19US FAERS
105Poor quality drug administeredFAERS: 19US FAERS
106Respiratory distressFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
107Emergency CareFAERS: 18US FAERS
108Product formulation issueFAERS: 18US FAERS
109Abdominal discomfortFAERS: 17US FAERS
110General physical health deteriorationFAERS: 17US FAERS
111Lower respiratory tract infectionFAERS: 17
Canada Vigilance: 10
Canada Vigilance
US FAERS
112Pulmonary congestionFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
113AnosmiaFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
114Blood glucose increasedFAERS: 16US FAERS
115Device difficult to useFAERS: 16US FAERS
116Intercepted medication errorFAERS: 16US FAERS
117ArthritisFAERS: 15
Canada Vigilance: 6
Canada Vigilance
US FAERS
118Device deployment issueFAERS: 15US FAERS
119DiscomfortFAERS: 15US FAERS
120Emergency care examinationFAERS: 15US FAERS
121Intentional drug misuseFAERS: 15US FAERS
122Intercepted drug administration errorFAERS: 15US FAERS
123Product label confusionFAERS: 15US FAERS
124Respiratory arrestFAERS: 15US FAERS
125Accidental underdoseFAERS: 14US FAERS
126AgitationFAERS: 14US FAERS
127Respiratory FailureFAERS: 14
Canada Vigilance: 4
Canada Vigilance
US FAERS
128Secretion dischargeFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
129Activities of daily living impairedFAERS: 13US FAERS
130Device breakageFAERS: 13US FAERS
131DisabilityFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
132EpistaxisFAERS: 13US FAERS
133Prescribed overdoseFAERS: 13US FAERS
134Product preparation errorFAERS: 13US FAERS
135SyncopeFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
136TachycardiaFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
137Therapeutic response unexpectedFAERS: 13US FAERS
138Weight decreasedFAERS: 13US FAERS
139AmnesiaFAERS: 12US FAERS
140BlindnessFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
141Blood alcohol increasedFAERS: 12US FAERS
142Cataract operationFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
143Choking sensationFAERS: 12US FAERS
144Increased upper airway secretionFAERS: 12US FAERS
145InfectionFAERS: 12
Canada Vigilance: 7
Canada Vigilance
US FAERS
146Medical device complicationFAERS: 12US FAERS
147Quality of life decreasedFAERS: 12US FAERS
148Reaction to drug excipientsFAERS: 12US FAERS
149StomatitisFAERS: 12US FAERS
150ThrombosisFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
151AgeusiaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
152Device use issueFAERS: 11US FAERS
153Drug screen positiveFAERS: 11US FAERS
154InflammationFAERS: 11US FAERS
155Lower respiratory tract congestionFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
156Product prescribing errorFAERS: 11US FAERS
157SwellingFAERS: 11US FAERS
158Visual ImpairmentFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
159Accidental overdoseFAERS: 10US FAERS
160Apparent deathFAERS: 10US FAERS
161Back disorderFAERS: 10US FAERS
162CataractFAERS: 10
Canada Vigilance: 6
Canada Vigilance
US FAERS
163Emotional distressFAERS: 10US FAERS
164FlushingFAERS: 10US FAERS
165Foreign body aspirationFAERS: 10US FAERS
166HypoxiaFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
167Lip swellingFAERS: 10US FAERS
168Oral painFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
169SneezingFAERS: 10US FAERS
170Wrong patient received productFAERS: 10US FAERS
171Amphetamines positiveFAERS: 9US FAERS
172Diabetes MellitusFAERS: 9
Canada Vigilance: 15
Canada Vigilance
US FAERS
173Expired drug administeredFAERS: 9US FAERS
174Exposure via eye contactFAERS: 9US FAERS
175Inappropriate schedule of product administrationFAERS: 9US FAERS
176Product availability issueFAERS: 9US FAERS
177Product communication issueFAERS: 9US FAERS
178Product dispensing errorFAERS: 9US FAERS
179Product residue presentFAERS: 9US FAERS
180Therapy cessationFAERS: 9US FAERS
181Unevaluable eventFAERS: 9US FAERS
182AngerFAERS: 8US FAERS
183Atrial FibrillationFAERS: 8
Canada Vigilance: 4
Canada Vigilance
US FAERS
184Atypical pneumoniaFAERS: 8US FAERS
185Blood potassium decreasedFAERS: 8US FAERS
186Circumstance or information capable of leading to device use errorFAERS: 8US FAERS
187Cold sweatFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
188DehydrationFAERS: 8US FAERS
189DisorientationFAERS: 8US FAERS
190Eye painFAERS: 8US FAERS
191Live BirthFAERS: 8US FAERS
192PresyncopeFAERS: 8US FAERS
193SepsisFAERS: 8US FAERS
194ArthralgiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
195ChillsFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
196CyanosisFAERS: 7US FAERS
197Drug delivery system malfunctionFAERS: 7US FAERS
198DyspepsiaFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
199FibromyalgiaFAERS: 7
Canada Vigilance: 4
Canada Vigilance
US FAERS
200MyalgiaFAERS: 7US FAERS
201Oxygen supplementationFAERS: 7US FAERS
202Peripheral swellingFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
203PneumothoraxFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
204ScreamingFAERS: 7US FAERS
205SomnolenceFAERS: 7US FAERS
206Tongue discomfortFAERS: 7US FAERS
207Abdominal PainFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
208AphasiaFAERS: 6US FAERS
209AsphyxiaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
210Bronchial irritationFAERS: 6US FAERS
211CryingFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
212DementiaFAERS: 6US FAERS
213Device damageFAERS: 6US FAERS
214Drug DependenceFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
215Ear congestionFAERS: 6US FAERS
216Limb injuryFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
217Loss of personal independence in daily activitiesFAERS: 6
Canada Vigilance: 20
Canada Vigilance
US FAERS
218LymphadenopathyFAERS: 6US FAERS
219Macular degenerationFAERS: 6US FAERS
220Maternal exposure during pregnancyFAERS: 6US FAERS
221Musculoskeletal chest painFAERS: 6US FAERS
222Product packaging issueFAERS: 6US FAERS
223Therapy non-responderFAERS: 6US FAERS
224TinnitusFAERS: 6US FAERS
225AbasiaFAERS: 5US FAERS
226Alcohol test false positiveFAERS: 5US FAERS
227AneurysmFAERS: 5US FAERS
228BedriddenFAERS: 5US FAERS
229Blood count abnormalFAERS: 5
Canada Vigilance: 24
Canada Vigilance
US FAERS
230Cardiac ArrestFAERS: 5US FAERS
231DeafnessFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
232Device primingFAERS: 5US FAERS
233Drug diversionFAERS: 5US FAERS
234Expired device usedFAERS: 5US FAERS
235Eye irritationFAERS: 5US FAERS
236HerniaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
237Hospice CareFAERS: 5US FAERS
238HyperventilationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
239Intervertebral Disc DegenerationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
240Living in residential institutionFAERS: 5US FAERS
241Medical induction of comaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
242Middle insomniaFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
243No adverse eventFAERS: 5US FAERS
244Oropharyngeal discomfortFAERS: 5US FAERS
245OsteoporosisFAERS: 5
Canada Vigilance: 4
Canada Vigilance
US FAERS
246Poor quality sleepFAERS: 5US FAERS
247Product administered to patient of inappropriate ageFAERS: 5US FAERS
248Pulmonary thrombosisFAERS: 5US FAERS
249Rehabilitation therapyFAERS: 5US FAERS
250Rotator cuff syndromeFAERS: 5US FAERS
251Sinus TachycardiaFAERS: 5US FAERS
252Sinus headacheFAERS: 5US FAERS
253Therapy changeFAERS: 5US FAERS
254Upper-airway cough syndromeFAERS: 5US FAERS
255VertigoFAERS: 5US FAERS
256Wrong drug administeredFAERS: 5US FAERS
257Acute respiratory failureFAERS: 4US FAERS
258Anaphylactic shockFAERS: 4US FAERS
259Apparent life threatening eventFAERS: 4US FAERS
260Application site erythemaFAERS: 4US FAERS
261ArthropathyFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
262Cardiac FlutterFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
263ConstipationFAERS: 4US FAERS
264Disease recurrenceFAERS: 4US FAERS
265Documented hypersensitivity to administered drugFAERS: 4US FAERS
266Drug abuseFAERS: 4US FAERS
267Drug administered in wrong deviceFAERS: 4US FAERS
268Drug screen false positiveFAERS: 4US FAERS
269DysuriaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
270ExcoriationFAERS: 4US FAERS
271FlatulenceFAERS: 4US FAERS
272Foaming at mouthFAERS: 4US FAERS
273GoutFAERS: 4US FAERS
274Grip strength decreasedFAERS: 4US FAERS
275HypotensionFAERS: 4US FAERS
276Impaired driving abilityFAERS: 4US FAERS
277Injury associated with deviceFAERS: 4US FAERS
278Intestinal ObstructionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
279Joint injuryFAERS: 4US FAERS
280Joint swellingFAERS: 4US FAERS
281LymphomaFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
282Muscle strainFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
283Muscle tightnessFAERS: 4US FAERS
284Musculoskeletal PainFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
285Paradoxical drug reactionFAERS: 4US FAERS
286Product contaminationFAERS: 4US FAERS
287Product distribution issueFAERS: 4US FAERS
288Product leakageFAERS: 4US FAERS
289Product measured potency issueFAERS: 4US FAERS
290Product packaging confusionFAERS: 4US FAERS
291RalesFAERS: 4US FAERS
292RhinitisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
293TensionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
294Therapeutic product effect decreasedFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
295Therapeutic product effect incompleteFAERS: 4
Canada Vigilance: 32
Canada Vigilance
US FAERS
296Therapeutic response delayedFAERS: 4US FAERS
297Tooth ErosionFAERS: 4US FAERS
298Tooth LossFAERS: 4US FAERS
299Upper respiratory tract congestionFAERS: 4US FAERS
300Urinary IncontinenceFAERS: 4US FAERS
301Urinary RetentionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
302Viral upper respiratory tract infectionFAERS: 4US FAERS
303cancer surgeryFAERS: 4US FAERS
304nervous system disorderFAERS: 4US FAERS
305Accidental device ingestionFAERS: 3US FAERS
306Accidental exposure to product by childFAERS: 3US FAERS
307Ankle FractureFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
308Blood glucose abnormalFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
309BronchopneumoniaFAERS: 3US FAERS
310CandidiasisFAERS: 3US FAERS
311CheilitisFAERS: 3US FAERS
312Chemical injuryFAERS: 3US FAERS
313ConjunctivitisFAERS: 3US FAERS
314Dental cariesFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
315Depressed moodFAERS: 3US FAERS
316Device dispensing errorFAERS: 3US FAERS
317Device physical property issueFAERS: 3US FAERS
318Disease ProgressionFAERS: 3US FAERS
319Drug dispensing issueFAERS: 3US FAERS
320Drug toxicityFAERS: 3US FAERS
321EpilepsyFAERS: 3US FAERS
322Feeling ColdFAERS: 3US FAERS
323Food PoisoningFAERS: 3US FAERS
324Foreign body traumaFAERS: 3US FAERS
325GlossitisFAERS: 3US FAERS
326Head discomfortFAERS: 3US FAERS
327Humidity intoleranceFAERS: 3US FAERS
328Incorrect drug administration durationFAERS: 3US FAERS
329Intercepted drug prescribing errorFAERS: 3US FAERS
330Intracranial AneurysmFAERS: 3US FAERS
331Lung neoplasm surgeryFAERS: 3US FAERS
332Mechanical ventilationFAERS: 3US FAERS
333Mental impairmentFAERS: 3US FAERS
334Metabolic acidosisFAERS: 3US FAERS
335Metastatic NeoplasmFAERS: 3US FAERS
336MonoplegiaFAERS: 3US FAERS
337Mouth swellingFAERS: 3US FAERS
338Nasal discomfortFAERS: 3US FAERS
339Night sweatsFAERS: 3US FAERS
340Off label use of deviceFAERS: 3US FAERS
341PallorFAERS: 3US FAERS
342PharyngitisFAERS: 3US FAERS
343Poor quality device usedFAERS: 3US FAERS
344PregnancyFAERS: 3US FAERS
345Product expiration date issueFAERS: 3US FAERS
346Product used for unknown indicationFAERS: 3US FAERS
347Rash erythematousFAERS: 3US FAERS
348RegurgitationFAERS: 3US FAERS
349Respiratory tract infection viralFAERS: 3US FAERS
350RestlessnessFAERS: 3US FAERS
351SarcoidosisFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
352Skin lesionFAERS: 3US FAERS
353Therapeutic product ineffectiveFAERS: 3US FAERS
354Throat cancerFAERS: 3US FAERS
355Umbilical herniaFAERS: 3US FAERS
356Urine alcohol test positiveFAERS: 3US FAERS
357treatment failureFAERS: 3US FAERS
358Accidental exposure to product packagingFAERS: 2US FAERS
359Acute myocardial infarctionFAERS: 2US FAERS
360Alanine Aminotransferase IncreasedFAERS: 2US FAERS
361AlopeciaFAERS: 2US FAERS
362Aortic AneurysmFAERS: 2US FAERS
363Aphthous StomatitisFAERS: 2US FAERS
364ArteriosclerosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
365Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
366Bladder prolapseFAERS: 2US FAERS
367Blood cholesterol increasedFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
368Blood glucose decreasedFAERS: 2US FAERS
369Blood sodium decreasedFAERS: 2US FAERS
370BradycardiaFAERS: 2US FAERS
371Bronchial secretion retentionFAERS: 2US FAERS
372CardiomegalyFAERS: 2US FAERS
373Cerebral disorderFAERS: 2US FAERS
374ChemotherapyFAERS: 2US FAERS
375Chronic diseaseFAERS: 2US FAERS
376Coating in mouthFAERS: 2US FAERS
377CystitisFAERS: 2US FAERS
378CystFAERS: 2US FAERS
379DependenceFAERS: 2US FAERS
380Device used for unapproved scheduleFAERS: 2US FAERS
381Diaphragmatic spasmFAERS: 2US FAERS
382DissociationFAERS: 2US FAERS
383DiverticulitisFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
384DysarthriaFAERS: 2US FAERS
385DysphemiaFAERS: 2US FAERS
386Environmental ExposureFAERS: 2US FAERS
387Exposure during breast feedingFAERS: 2US FAERS
388False positive investigation resultFAERS: 2US FAERS
389Food AllergyFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
390Foreign body in respiratory tractFAERS: 2US FAERS
391Frustration tolerance decreasedFAERS: 2US FAERS
392FrustrationFAERS: 2US FAERS
393Gastric ulcerFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
394HypersomniaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
395HypophagiaFAERS: 2US FAERS
396HysterectomyFAERS: 2US FAERS
397Impaired gastric emptyingFAERS: 2US FAERS
398Impaired quality of lifeFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
399IncontinenceFAERS: 2US FAERS
400Incorrect drug administration rateFAERS: 2US FAERS
401Incorrect product administration durationFAERS: 2US FAERS
402Incorrect storage of drugFAERS: 2US FAERS
403Increased bronchial secretionFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
404Increased viscosity of bronchial secretionFAERS: 2US FAERS
405Increased viscosity of upper respiratory secretionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
406Initial insomniaFAERS: 2US FAERS
407Intra-abdominal fluid collectionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
408Irritable Bowel SyndromeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
409LacerationFAERS: 2US FAERS
410LethargyFAERS: 2US FAERS
411LeukocytosisFAERS: 2US FAERS
412Limb discomfortFAERS: 2US FAERS
413Limb fractureFAERS: 2US FAERS
414MaculeFAERS: 2US FAERS
415Mass excisionFAERS: 2US FAERS
416Mastication disorderFAERS: 2US FAERS
417Neck PainFAERS: 2US FAERS
418Non-cardiac chest painFAERS: 2US FAERS
419Nonspecific reactionFAERS: 2US FAERS
420Oral mucosal erythemaFAERS: 2US FAERS
421Oxygen consumption decreasedFAERS: 2US FAERS
422Oxygen consumption increasedFAERS: 2US FAERS
423Panic DisorderFAERS: 2US FAERS
424PneumonectomyFAERS: 2US FAERS
425Poor peripheral circulationFAERS: 2US FAERS
426Product administration errorFAERS: 2US FAERS
427Product container issueFAERS: 2US FAERS
428Product dosage form issueFAERS: 2US FAERS
429Product label issueFAERS: 2US FAERS
430Product lot number issueFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
431Pulmonary EmbolismFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
432Pulmonary HypertensionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
433Pulmonary function test decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
434Rectal dischargeFAERS: 2US FAERS
435Regurgitation of foodFAERS: 2US FAERS
436RetinopexyFAERS: 2US FAERS
437ScabFAERS: 2US FAERS
438SciaticaFAERS: 2US FAERS
439Sensitivity to weather changeFAERS: 2US FAERS
440ShockFAERS: 2US FAERS
441Skeletal injuryFAERS: 2US FAERS
442Spinal fusion surgeryFAERS: 2US FAERS
443Stevens-Johnson SyndromeFAERS: 2US FAERS
444Sudden deathFAERS: 2US FAERS
445Suicide attemptFAERS: 2US FAERS
446SunburnFAERS: 2US FAERS
447Suspected counterfeit productFAERS: 2US FAERS
448Terminal stateFAERS: 2US FAERS
449Therapeutic response changedFAERS: 2US FAERS
450Tongue blisteringFAERS: 2US FAERS
451Total lung capacity abnormalFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
452Urinary tract infectionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
453Vascular stent insertionFAERS: 2US FAERS
454Wheelchair userFAERS: 2US FAERS
455Wrong doseFAERS: 2US FAERS
456Wrong product administeredFAERS: 2US FAERS
457Accidental exposureFAERS: 1US FAERS
458AcneFAERS: 1US FAERS
459Acute Coronary SyndromeFAERS: 1US FAERS
460Acute kidney injuryFAERS: 1US FAERS
461AdenocarcinomaFAERS: 1US FAERS
462Administration site drynessFAERS: 1US FAERS
463Alcohol poisoningFAERS: 1US FAERS
464Allergic reaction to excipientFAERS: 1US FAERS
465Allergy to chemicalsFAERS: 1US FAERS
466Anaphylactoid ReactionFAERS: 1US FAERS
467Angina PectorisFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
468AngioedemaFAERS: 1US FAERS
469AnhedoniaFAERS: 1US FAERS
470Anorectal discomfortFAERS: 1US FAERS
471AnorexiaFAERS: 1US FAERS
472AnoxiaFAERS: 1US FAERS
473AphagiaFAERS: 1US FAERS
474AppendicitisFAERS: 1US FAERS
475Arterial therapeutic procedureFAERS: 1US FAERS
476Arthropod biteFAERS: 1US FAERS
477AtelectasisFAERS: 1US FAERS
478Atrial FlutterFAERS: 1US FAERS
479Bacteria sputum identifiedFAERS: 1US FAERS
480Bile output abnormalFAERS: 1US FAERS
481BiopsyFAERS: 1US FAERS
482Bipolar DisorderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
483Bipolar I disorderFAERS: 1US FAERS
484Blood PressureFAERS: 1US FAERS
485Blood bromide increasedFAERS: 1US FAERS
486Blood creatine phosphokinase increasedFAERS: 1US FAERS
487Blood immunoglobulin E decreasedFAERS: 1US FAERS
488Blood immunoglobulin E increasedFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
489Blood insulin abnormalFAERS: 1US FAERS
490Body height abnormalFAERS: 1US FAERS
491Bone contusionFAERS: 1US FAERS
492Bone painFAERS: 1US FAERS
493BradyphreniaFAERS: 1US FAERS
494Bronchitis fungalFAERS: 1US FAERS
495Cardiac discomfortFAERS: 1US FAERS
496Cardiac enzymes increasedFAERS: 1US FAERS
497Cardiac valve ruptureFAERS: 1US FAERS
498Cardiac ventricular disorderFAERS: 1US FAERS
499CardiotoxicityFAERS: 1US FAERS
500Carotid artery occlusionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
501Carpal Tunnel SyndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
502Cartilage injuryFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
503Catheter placementFAERS: 1US FAERS
504Cauda Equina SyndromeFAERS: 1US FAERS
505Chemical burn of skinFAERS: 1US FAERS
506CholelithiasisFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
507ChromatopsiaFAERS: 1US FAERS
508ChromaturiaFAERS: 1US FAERS
509Chronic respiratory failureFAERS: 1US FAERS
510Clostridium difficile infectionFAERS: 1US FAERS
511ColectomyFAERS: 1US FAERS
512ColitisFAERS: 1US FAERS
513Completed SuicideFAERS: 1US FAERS
514Complication associated with deviceFAERS: 1US FAERS
515Concomitant disease aggravatedFAERS: 1US FAERS
516Consciousness fluctuatingFAERS: 1US FAERS
517Conversion disorderFAERS: 1US FAERS
518Coronary Artery DiseaseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
519Corrosive oropharyngeal injuryFAERS: 1US FAERS
520Creatinine renal clearance increasedFAERS: 1US FAERS
521Croup infectiousFAERS: 1US FAERS
522Deep Vein ThrombosisFAERS: 1US FAERS
523DeliriumFAERS: 1US FAERS
524Device chemical property issueFAERS: 1US FAERS
525Device dislocationFAERS: 1US FAERS
526Device effect variableFAERS: 1US FAERS
527Device material issueFAERS: 1US FAERS
528Device monitoring procedure not performedFAERS: 1US FAERS
529Diabetes mellitus inadequate controlFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
530Diabetic FootFAERS: 1US FAERS
531Diabetic KetoacidosisFAERS: 1US FAERS
532Disease complicationFAERS: 1US FAERS
533DiverticulumFAERS: 1US FAERS
534Drain placementFAERS: 1US FAERS
535DroolingFAERS: 1US FAERS
536Drug ToleranceFAERS: 1US FAERS
537Drug administered at inappropriate siteFAERS: 1US FAERS
538Drug dispensed to wrong patientFAERS: 1US FAERS
539Drug dose omission by deviceFAERS: 1US FAERS
540Drug effect variableFAERS: 1US FAERS
541Drug exposure during pregnancyFAERS: 1US FAERS
542Drug exposure via breast milkFAERS: 1US FAERS
543Drug level decreasedFAERS: 1US FAERS
544DysgraphiaFAERS: 1US FAERS
545DysplasiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
546Dyspnoea exacerbatedFAERS: 1US FAERS
547EczemaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
548Educational problemFAERS: 1US FAERS
549Electrocardiogram ST-T segment abnormalFAERS: 1US FAERS
550EmbolismFAERS: 1US FAERS
551Emotional disorderFAERS: 1US FAERS
552EnuresisFAERS: 1US FAERS
553Epigastric discomfortFAERS: 1US FAERS
554Erectile dysfunctionFAERS: 1US FAERS
555EructationFAERS: 1US FAERS
556Erythema MultiformeFAERS: 1US FAERS
557Essential TremorFAERS: 1US FAERS
558Exposure to allergenFAERS: 1US FAERS
559Exposure to contaminated deviceFAERS: 1US FAERS
560Exposure to unspecified agentFAERS: 1US FAERS
561Exposure via direct contactFAERS: 1US FAERS
562Exposure via inhalationFAERS: 1US FAERS
563Eye InfectionFAERS: 1US FAERS
564Eyelids pruritusFAERS: 1US FAERS
565Feeling of body temperature changeFAERS: 1US FAERS
566Flank PainFAERS: 1US FAERS
567FolliculitisFAERS: 1US FAERS
568Fracture treatmentFAERS: 1US FAERS
569FractureFAERS: 1US FAERS
570Gait inabilityFAERS: 1US FAERS
571GangreneFAERS: 1US FAERS
572Gastric mucosa erythemaFAERS: 1US FAERS
573Gastric stent insertionFAERS: 1US FAERS
574GastritisFAERS: 1US FAERS
575GastroenteritisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
576Gastrointestinal carcinomaFAERS: 1US FAERS
577Gastrointestinal ulcerFAERS: 1US FAERS
578General physical condition abnormalFAERS: 1US FAERS
579General symptomFAERS: 1US FAERS
580GingivitisFAERS: 1US FAERS
581Hair injuryFAERS: 1US FAERS
582Head BangingFAERS: 1US FAERS
583Head lagFAERS: 1US FAERS
584Hepatitis CFAERS: 1US FAERS
585Hepatorenal SyndromeFAERS: 1US FAERS
586Hip surgeryFAERS: 1US FAERS
587HypercapniaFAERS: 1US FAERS
588HypothyroidismFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
589Incorrect dose administered by productFAERS: 1US FAERS
590Incorrect drug dosage form administeredFAERS: 1US FAERS
591Incorrect route of product administrationFAERS: 1US FAERS
592InfarctionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
593Infectious MononucleosisFAERS: 1US FAERS
594Influenza A virus testFAERS: 1US FAERS
595Injection site injuryFAERS: 1US FAERS
596Injection site pruritusFAERS: 1US FAERS
597Intentional device use issueFAERS: 1US FAERS
598Intentional self-injuryFAERS: 1US FAERS
599Intercepted product dispensing errorFAERS: 1US FAERS
600Irregular breathingFAERS: 1US FAERS
601Keratosis pilarisFAERS: 1US FAERS
602LabyrinthitisFAERS: 1US FAERS
603Large intestine perforationFAERS: 1US FAERS
604Laryngeal ObstructionFAERS: 1US FAERS
605Limb massFAERS: 1US FAERS
606Limb operationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
607Lip erythemaFAERS: 1US FAERS
608Lip pruritusFAERS: 1US FAERS
609Liquid product physical issueFAERS: 1US FAERS
610MastectomyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
611Medical device discomfortFAERS: 1US FAERS
612Meniscus injuryFAERS: 1US FAERS
613MetastasisFAERS: 1US FAERS
614Mood swingsFAERS: 1US FAERS
615Morbid thoughtsFAERS: 1US FAERS
616Morning SicknessFAERS: 1US FAERS
617Mouth BreathingFAERS: 1US FAERS
618Multiple SclerosisFAERS: 1US FAERS
619Multiple sclerosis relapseFAERS: 1US FAERS
620Musculoskeletal discomfortFAERS: 1US FAERS
621Musculoskeletal stiffnessFAERS: 1US FAERS
622MydriasisFAERS: 1US FAERS
623Nasal PolypsFAERS: 1
Canada Vigilance: 5
Canada Vigilance
US FAERS
624Nasal inflammationFAERS: 1US FAERS
625Near DrowningFAERS: 1US FAERS
626Nerve injuryFAERS: 1US FAERS
627No reaction on previous exposure to drugFAERS: 1US FAERS
628NoduleFAERS: 1US FAERS
629Ocular discomfortFAERS: 1US FAERS
630Oral candidiasisFAERS: 1US FAERS
631Oral fungal infectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
632Orchitis noninfectiveFAERS: 1US FAERS
633Oropharyngeal blisteringFAERS: 1US FAERS
634Oropharyngeal candidiasisFAERS: 1US FAERS
635Oxygen ConsumptionFAERS: 1US FAERS
636Oxygen saturation abnormalFAERS: 1US FAERS
637PO2 abnormalFAERS: 1US FAERS
638Packaging design issueFAERS: 1US FAERS
639Palliative CareFAERS: 1US FAERS
640PancreatitisFAERS: 1US FAERS
641Paranasal sinus hypersecretionFAERS: 1US FAERS
642ParanoiaFAERS: 1US FAERS
643Pericardial effusionFAERS: 1US FAERS
644Personality ChangeFAERS: 1US FAERS
645PetechiaeFAERS: 1US FAERS
646Pharyngeal swellingFAERS: 1US FAERS
647Pharyngolaryngeal PainFAERS: 1US FAERS
648Physical assaultFAERS: 1US FAERS
649Pleuritic painFAERS: 1US FAERS
650Pneumococcal sepsisFAERS: 1US FAERS
651PneumoconiosisFAERS: 1US FAERS
652PneumonitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
653PoisoningFAERS: 1US FAERS
654Post-Traumatic Stress DisorderFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
655Prescribed underdoseFAERS: 1US FAERS
656Product container seal issueFAERS: 1US FAERS
657Product contamination microbialFAERS: 1US FAERS
658Product contamination physicalFAERS: 1US FAERS
659Product design confusionFAERS: 1US FAERS
660Product design issueFAERS: 1US FAERS
661Product outer packaging issueFAERS: 1US FAERS
662Product physical consistency issueFAERS: 1US FAERS
663Product prescribing issueFAERS: 1US FAERS
664Product quality control issueFAERS: 1US FAERS
665Product solubility abnormalFAERS: 1US FAERS
666PsoriasisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
667Pulmonary FibrosisFAERS: 1US FAERS
668Reaction to excipientFAERS: 1US FAERS
669Reaction to preservativesFAERS: 1US FAERS
670Renal Cell CarcinomaFAERS: 1US FAERS
671Renal artery occlusionFAERS: 1US FAERS
672Respiratory TherapyFAERS: 1US FAERS
673Respiratory tract inflammationFAERS: 1US FAERS
674Restless Legs SyndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
675Rheumatoid ArthritisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
676RhinalgiaFAERS: 1US FAERS
677Rhinovirus infectionFAERS: 1US FAERS
678RhonchiFAERS: 1US FAERS
679Root canal infectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
680Saliva alcohol test positiveFAERS: 1US FAERS
681Sinus polypFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
682Sinusitis noninfectiveFAERS: 1US FAERS
683Skin UlcerFAERS: 1US FAERS
684Skin irritationFAERS: 1US FAERS
685Skin reactionFAERS: 1US FAERS
686Slow speechFAERS: 1US FAERS
687Spinal StenosisFAERS: 1US FAERS
688SplenectomyFAERS: 1US FAERS
689Splenic embolismFAERS: 1US FAERS
690SpondylolisthesisFAERS: 1US FAERS
691StaringFAERS: 1US FAERS
692Status AsthmaticusFAERS: 1US FAERS
693Stoma creationFAERS: 1US FAERS
694StridorFAERS: 1US FAERS
695Sudden Cardiac DeathFAERS: 1US FAERS
696Sudden onset of sleepFAERS: 1US FAERS
697Suspected product tamperingFAERS: 1US FAERS
698Symptom maskedFAERS: 1US FAERS
699Symptom recurrenceFAERS: 1US FAERS
700Temperature regulation disorderFAERS: 1US FAERS
701Tension HeadacheFAERS: 1US FAERS
702Therapeutic procedureFAERS: 1US FAERS
703Therapeutic product ineffective for unapproved indicationFAERS: 1US FAERS
704ThirstFAERS: 1US FAERS
705Throat clearingFAERS: 1US FAERS
706Tobacco userFAERS: 1US FAERS
707Tongue erythemaFAERS: 1US FAERS
708ToothacheFAERS: 1US FAERS
709Toxicity to various agentsFAERS: 1US FAERS
710Tracheal dilatationFAERS: 1US FAERS
711Traumatic liver injuryFAERS: 1US FAERS
712Troponin I increasedFAERS: 1US FAERS
713UlcerFAERS: 1US FAERS
714Unable to afford prescribed medicationFAERS: 1US FAERS
715Unresponsive to stimuliFAERS: 1US FAERS
716Urinary hesitationFAERS: 1US FAERS
717Urine amphetamine positiveFAERS: 1US FAERS
718Vascular ruptureFAERS: 1US FAERS
719Vascular testFAERS: 1US FAERS
720Ventricular arrhythmiaFAERS: 1US FAERS
721Ventricular hypokinesiaFAERS: 1US FAERS
722Visual disturbanceFAERS: 1US FAERS
723Vocal Cord ParalysisFAERS: 1US FAERS
724Walking aid userFAERS: 1US FAERS
725YawningFAERS: 1US FAERS
726angiogramFAERS: 1US FAERS
727colonoscopyFAERS: 1US FAERS
728diagnostic procedureFAERS: 1US FAERS
729furuncleFAERS: 1US FAERS
730intensive careFAERS: 1US FAERS
731jaundiceFAERS: 1US FAERS
732muscle injuryFAERS: 1US FAERS
733Abdominal adhesionsCanada Vigilance: 1Canada Vigilance
734AbscessCanada Vigilance: 1Canada Vigilance
735Benign Prostatic HyperplasiaCanada Vigilance: 1Canada Vigilance
736Blood cholesterol abnormalCanada Vigilance: 1Canada Vigilance
737Blood immunoglobulin E abnormalCanada Vigilance: 1Canada Vigilance
738Breast FeedingCanada Vigilance: 1Canada Vigilance
739Breast hyperplasiaCanada Vigilance: 1Canada Vigilance
740Bronchial HyperreactivityCanada Vigilance: 1Canada Vigilance
741Bronchial ObstructionCanada Vigilance: 2Canada Vigilance
742BronchiectasisCanada Vigilance: 2Canada Vigilance
743Bronchopulmonary AspergillosisCanada Vigilance: 3Canada Vigilance
744Carbon dioxide increasedCanada Vigilance: 1Canada Vigilance
745Cardiac autonomic neuropathyCanada Vigilance: 1Canada Vigilance
746Cardiac dysfunctionCanada Vigilance: 1Canada Vigilance
747CellulitisCanada Vigilance: 1Canada Vigilance
748Chronic Spontaneous UrticariaCanada Vigilance: 1Canada Vigilance
749Chronic sinusitisCanada Vigilance: 4Canada Vigilance
750Cortisol decreasedCanada Vigilance: 1Canada Vigilance
751Cystic FibrosisCanada Vigilance: 2Canada Vigilance
752Dependence on oxygen therapyCanada Vigilance: 1Canada Vigilance
753Dry age-related macular degenerationCanada Vigilance: 1Canada Vigilance
754EndometriosisCanada Vigilance: 1Canada Vigilance
755EosinophiliaCanada Vigilance: 1Canada Vigilance
756Eosinophilic PneumoniaCanada Vigilance: 1Canada Vigilance
757Eosinophilic bronchitisCanada Vigilance: 1Canada Vigilance
758Eosinophilic granulomatosis with polyangiitisCanada Vigilance: 5Canada Vigilance
759Feeding tube userCanada Vigilance: 1Canada Vigilance
760FibromatosisCanada Vigilance: 1Canada Vigilance
761Fungal pharyngitisCanada Vigilance: 1Canada Vigilance
762GastrectomyCanada Vigilance: 1Canada Vigilance
763Gastric hypomotilityCanada Vigilance: 1Canada Vigilance
764GlaucomaCanada Vigilance: 2Canada Vigilance
765Granulomatosis with polyangiitisCanada Vigilance: 1Canada Vigilance
766HemiparesisCanada Vigilance: 1Canada Vigilance
767HydronephrosisCanada Vigilance: 1Canada Vigilance
768HyperchlorhydriaCanada Vigilance: 1Canada Vigilance
769HyperoxiaCanada Vigilance: 1Canada Vigilance
770HypoventilationCanada Vigilance: 2Canada Vigilance
771ImmobileCanada Vigilance: 1Canada Vigilance
772ImmunosuppressionCanada Vigilance: 1Canada Vigilance
773Intestinal PerforationCanada Vigilance: 1Canada Vigilance
774Intestinal metaplasiaCanada Vigilance: 1Canada Vigilance
775Lung hyperinflationCanada Vigilance: 3Canada Vigilance
776Microbiology test abnormalCanada Vigilance: 1Canada Vigilance
777Myotonic DystrophyCanada Vigilance: 1Canada Vigilance
778NephrolithiasisCanada Vigilance: 1Canada Vigilance
779ObstructionCanada Vigilance: 1Canada Vigilance
780OsteopeniaCanada Vigilance: 1Canada Vigilance
781Paranasal biopsyCanada Vigilance: 1Canada Vigilance
782Paranasal sinus polypectomyCanada Vigilance: 2Canada Vigilance
783Peptic UlcerCanada Vigilance: 1Canada Vigilance
784PericarditisCanada Vigilance: 2Canada Vigilance
785Postoperative ileusCanada Vigilance: 1Canada Vigilance
786Protein S DeficiencyCanada Vigilance: 1Canada Vigilance
787Psychiatric symptomCanada Vigilance: 1Canada Vigilance
788Pulmonary painCanada Vigilance: 2Canada Vigilance
789PyelonephritisCanada Vigilance: 1Canada Vigilance
790Restrictive pulmonary diseaseCanada Vigilance: 2Canada Vigilance
791Retinal DetachmentCanada Vigilance: 1Canada Vigilance
792Serotonin SyndromeCanada Vigilance: 1Canada Vigilance
793Sinus operationCanada Vigilance: 1Canada Vigilance
794Sinusitis aspergillusCanada Vigilance: 1Canada Vigilance
795Sjogren's SyndromeCanada Vigilance: 1Canada Vigilance
796Sleep disorder due to a general medical conditionCanada Vigilance: 8Canada Vigilance
797Steroid diabetesCanada Vigilance: 1Canada Vigilance
798SuperinfectionCanada Vigilance: 1Canada Vigilance
799Supraventricular tachycardiaCanada Vigilance: 1Canada Vigilance
800ThymomaCanada Vigilance: 1Canada Vigilance
801ThyroidectomyCanada Vigilance: 1Canada Vigilance
802Vertebral Artery DissectionCanada Vigilance: 1Canada Vigilance
803Vulvovaginal pruritusCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.